Related Experiment Video

Updated: Oct 23, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

Direct medical charges associated with myocardial infarction in patients with and without diabetes

T L Smith1, C A Melfi, J A Kesterson

  • 1Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. tlsmith@lilly.com

Medical Care
|April 27, 1999
PubMed

Insights

Patients with diabetes incur higher medical costs after myocardial infarction. These costs are primarily driven by hospitalizations, highlighting the need for cost-effectiveness evaluations of new diabetes and cardiovascular therapies.

Area of Science:

  • Cardiology
  • Diabetology
  • Health Economics

Background:

  • Diabetes mellitus is a significant risk factor for cardiovascular disease.
  • Myocardial infarction (MI) management and outcomes are influenced by comorbid diabetes.

Purpose of the Study:

  • To quantify and compare the direct medical charges associated with myocardial infarction in patients with and without diabetes.

Main Methods:

  • Retrospective cohort analysis from a third-party payer perspective.
  • Inclusion of 293 patients (87 with diabetes, 206 without) within 12 months post-myocardial infarction.
  • Data collected between January 1993 and February 1997.

Main Results:

  • Patients with diabetes incurred higher total direct medical charges ($26,414 vs. $18,577) post-myocardial infarction.
  • Hospitalizations constituted 88% of total direct medical charges for both groups.
  • Higher mean charges for initial and follow-up cardiovascular-related hospitalizations were observed in patients with diabetes.

Conclusions:

  • Diabetes significantly increases direct medical costs following myocardial infarction.
  • Findings support cost-effectiveness analyses for diabetes-specific and macrovascular complication-reducing therapies in post-MI patients.
Abstract

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...